Mayne Pharma Group Financial Overview
Mayne Pharma Group's market cap is currently AU$254.30M. The company's EPS TTM is AU$-0.841; its P/E ratio is -2.71; Mayne Pharma Group is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
